//--> //--> //-->
Toggle navigation
Logout
Change account settings
EN
DE
ES
FR
A-Z
Beta
About EconBiz
News
Thesaurus (STW)
Research Skills
Help
EN
DE
ES
FR
My account
Logout
Change account settings
Login
Publications
Events
Your search terms
Search
Retain my current filters
~institution:"CESifo"
~subject:"longevity"
~subject:"venture capital"
Search options
All Fields
Title
Exact title
Subject
Author
Institution
ISBN/ISSN
Published in...
Publisher
Open Access only
Advanced
Search history
My EconBiz
Favorites
Loans
Reservations
Fines
You are here:
Home
Innovation and R&D Activities...
Similar by subject
Narrow search
Delete all filters
| 3 applied filters
Year of publication
From:
To:
Subject
All
longevity
venture capital
innovation
50
growth
7
R&D
6
entrepreneurship
4
R&D subsidies
3
directed technical change
3
imitation
3
intellectual property rights
3
productivity
3
spillovers
3
climate change
2
competition
2
cooperation
2
delegation
2
double moral hazard
2
economic growth
2
energy
2
environmental policy
2
human capital
2
incentives
2
market entry
2
non-renewable resources
2
panel data
2
pharmaceutical
2
product cycle
2
reciprocity
2
research and development
2
rig services
2
social exchange
2
technical change
2
wages
2
American Exchange options
1
CCS
1
CO2
1
European Union
1
German automotive industry
1
German manufacturing firms
1
Greece
1
more ...
less ...
Online availability
All
Free
4
Type of publication
All
Book / Working Paper
4
Language
All
English
2
Undetermined
2
Author
All
Keuschnigg, Christian
2
Lichtenberg, Frank
2
Pettersson, Billie
1
Institution
All
CESifo
C.E.P.R. Discussion Papers
7
Economics Department, Organisation de Coopération et de Développement Économiques (OCDE)
5
Centre for Research into Industry, Enterprise, Finance and the Firm (CRIEFF), University of St. Andrews
3
Volkswirtschaftliche Fakultät, Ludwig-Maximilians-Universität München
3
Barcelona Graduate School of Economics (Barcelona GSE)
2
Cowles Foundation for Research in Economics, Yale University
2
Economics Department, European Investment Bank (EIB)
2
Institut d'Économie Industrielle (IDEI), Toulouse School of Economics (TSE)
2
Institute of Business and Economic Research (IBER), Walter A. Haas School of Business
2
Toulouse School of Economics (TSE)
2
Center for Global, International and Regional Studies, UC Santa Cruz
1
Centre Emile Bernheim, Solvay Brussels School of Economics and Management
1
Department of Economics, University of Pennsylvania
1
Dipartimento di Economia e Finanza (DEF), Libera Università Internazionale degli Studi Sociali Guido Carli (LUISS)
1
EconWPA
1
Economic Commission for Europe (UN-ECE), United Nations
1
Elinkeinoelämän Tutkimuslaitos (ETLA)
1
Erasmus Research Institute of Management (ERIM), Erasmus Universiteit Rotterdam
1
Faculteit Economie en Bedrijfskunde, Universiteit Gent
1
Faculty of Economics, University of Cambridge
1
Groupe de REcherche en Droit, Économie, Gestion (GREDEG), Institut Supérieur d'Économie et Management (ISEM)
1
HAL
1
Institut für Volkswirschaftlehre, Fakultät für Wirtschaftswissenschaften
1
Núcleo de Investigação em Políticas Económicas (NIPE), Universidade do Minho
1
School of Economics and Political Science, Universität St. Gallen
1
Society for Economic Dynamics - SED
1
Suomen Pankki
1
Tilburg University, Center for Economic Research
1
United Nations University, Maastricht Economic and social Research and training centre on Innovation and Technology
1
United Nations University-Maastricht Economic Research Institute of Innovation and Technology (UNU-MERIT)
1
Universität Mannheim
1
Zentrum für Europäische Wirtschaftsforschung (ZEW)
1
more ...
less ...
Published in...
All
CESifo Working Paper Series
4
Source
All
RePEc
4
Showing
1
-
4
of
4
Sort
relevance
articles prioritized
date (newest first)
date (oldest first)
1
Pharmaceutical
Innovation
, Longevity, and Medical Expenditure in Greece, 1995-2010
Lichtenberg, Frank
-
CESifo
-
2015
Longitudinal, disease-level data are used to analyze the impact of pharmaceutical
innovation
on longevity (mean age at … pharmaceutical
innovation
increased mean age at death by 0.87 years (10.4 months)-—about 44% of the total increase in longevity … pharmaceutical
innovation
. The baseline estimate of the cost per life-year gained from pharmaceutical
innovation
in Greece is $17 …
Persistent link: https://www.econbiz.de/10011122677
Saved in:
2
The Impact of Pharmaceutical
Innovation
on Longevity and Medical Expenditure in Sweden, 1997-2010: Evidence from Longitudinal, Disease-Level Data
Lichtenberg, Frank
;
Pettersson, Billie
-
CESifo
-
2012
We use longitudinal, disease-level data to analyze the impact of pharmaceutical
innovation
on longevity and medical … expenditure in Sweden, where mean age at death increased by 1.88 years during the period 1997-2010. Pharmaceutical
innovation
is … the number of drugs to treat a disease, not the number of drug classes. Pharmaceutical
innovation
also reduced hospital …
Persistent link: https://www.econbiz.de/10010569681
Saved in:
3
Public Policy and Venture Capital Backed
Innovation
Keuschnigg, Christian
-
CESifo
-
2003
gains taxation,
innovation
subsidies, public R&D spending and other policy initiatives. …
Persistent link: https://www.econbiz.de/10005766108
Saved in:
4
Venture Capital Backed Growth
Keuschnigg, Christian
-
CESifo
-
2002
The paper proposes a simple equilibrium model of venture capital, entrepreneurship and
innovation
. Venture capitalists … productive and active VC industry boosts
innovation
driven growth. …
Persistent link: https://www.econbiz.de/10005405803
Saved in:
Results per page
10
25
50
100
250
A service of the
zbw
×
Loading...
//-->